Novavax developing combination flu, Covid vaccine

Novavax developing combination flu, Covid vaccine
Novavax developing combination flu, Covid vaccine

Hello and welcome to the details of Novavax developing combination flu, Covid vaccine and now with the details

Nevin Al Sukari - Sana'a - The company said a study showed that the shot produced strong levels of antibodies. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


WSHINGTON, May 10 — US biotech firm Novavax today said it had positive results from preclinical studies of a shot combining its influenza and Covid vaccine candidates.

The company said a study, which it has posted to a preprint server and will now undergo peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters.

“Despite low rates during the Covid-19 pandemic, influenza remains a significant risk to global public health and the need for versatile, more effective vaccines is as important as ever, including against the flu,” said Gregory Glenn, the company’s president of R&D. 

The new vaccine combines NanoFlu and NVX-CoV2373, which are separately in late-stage human trials. Neither have yet been approved.

Hamsters that were vaccinated and then deliberately infected with the coronavirus retained their body weight compared to those that received a placebo.

Lung samples taken from the immunized animals after they were put down showed they were Covid-free.

NVX-CoV2373, the company’s Covid vaccine candidate, demonstrated 100 percent protection against severe disease in a Phase 3 clinical trial in the United Kingdom, with 89.7 per cent efficacy against any form of disease.

NVX-CoV2373 uses a piece of the SARS-CoV-2 virus called the spike protein, which the company mass produces inside insect cells.

It packages the spike inside nanoparticles and delivers these to the immune system, which trains the host in case they encounter the real virus.

The vaccine contains a substance called an adjuvant to deliver a stronger signal to the immune system to respond.

NanoFlu is based on similar principles but instead of the spike protein, it presents hemagglutinin—a protein on the outside of the influenza virus—to the immune system. — AFP

These were the details of the news Novavax developing combination flu, Covid vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Thai PM sorry for Covid-19 vaccination delays
NEXT CNN anchor Christiane Amanpour being treated for ovarian cancer